8-K: Cardlytics Completes $50 Million At-the-Market Offering

Cardlytics, Inc. successfully completed a $50 million at-the-market offering by selling 3,907,600 shares of its common stock.

Summary

• Cardlytics, Inc. entered into an Equity Distribution Agreement on March 18, 2024, allowing them to sell shares of common stock up to $50 million.
• The company sold 3,907,600 shares at a weighted average price of $12.80 per share.
• This sale resulted in gross proceeds of $50 million, completing the at-the-market offering program.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the company successfully completed a planned capital raise. There are no indications of negative impacts or surprises.

Positives

• Cardlytics successfully raised $50 million in gross proceeds.
• The at-the-market offering program was completed as planned.

Industry Context

At-the-market offerings are a common method for companies to raise capital, especially in the technology sector. This allows companies to take advantage of market conditions to sell shares over time.

Comparison to Industry Standards

• Many technology companies use at-the-market offerings to raise capital, especially when they need to fund growth or operations.
• The size of this offering, $50 million, is relatively common for a company of Cardlytics' size and market capitalization.
• Comparable companies that have used ATM offerings include those in the fintech and adtech spaces, such as PubMatic and Magnite.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• The company now has additional capital to fund operations and growth.

Key Dates

Keywords

at-the-market offering, equity distribution, capital raise, common stock, Cardlytics, CDLX